TAK-625
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for TAK-625, covering 2024-09-24 to 2024-10-15. Get the full timeline:
Most recent: Clinical Trial Update: A Study of TAK-625 for the Treatment of Alagille Syndrome (ALGS) [Phase 3]